National Guideline Clearinghouse | Ranibizumab for treating diabetic macular oedema (rapid review of technology appraisal guidance 237).

full-text ►
National Guideline Clearinghouse | Ranibizumab for treating diabetic macular oedema (rapid review of technology appraisal guidance 237).

July 15, 2013

Guideline Title

Ranibizumab for treating diabetic macular oedema (rapid review of technology appraisal guidance 237).

 

Bibliographic Source(s)

National Institute for Health and Clinical Excellence (NICE). Ranibizumab for treating diabetic macular oedema (rapid review of technology appraisal guidance 237). London (UK): National Institute for Health and Clinical Excellence (NICE); 2013 Apr. 75 p. (Technology appraisal guidance; no. 274).

 

Guideline Status

This is the current release of the guideline.